Blood Test Predicts Alzheimer's Onset Age | NIH Study
Explore the NIH-funded blood test using p-tau217 that predicts Alzheimer's symptom onset within 3-4 years, led by WashU researchers. Implications for trials and prevention.
No reviews yet. Be the first to rate Suzanne!
Suzanne E. Schindler, MD, PhD, is Associate Professor of Neurology, Aging & Dementia at Washington University School of Medicine in St. Louis. She completed the Medical Scientist Training Program, earning both her MD and PhD in Neuroscience in 2008 from Washington University in St. Louis School of Medicine. She subsequently completed a neurology residency in 2012 and a dementia fellowship in 2014, all at the same institution. Dr. Schindler is a clinical neurologist and neuroscientist whose work focuses on improving the diagnosis and treatment of Alzheimer disease and related disorders. She sees patients with memory concerns at the Washington University Memory Diagnostic Center and coordinates clinical biomarker testing there. She leads the Fluid Biomarker Core for the Knight Alzheimer Disease Research Center, where her laboratory develops and validates blood and cerebrospinal fluid biomarkers for Alzheimer disease and related conditions. Her research includes leading studies on early blood biomarkers of Alzheimer disease and developing approaches to understand biomarker changes over the disease course, with an emphasis on clinical validation of blood tests and appropriate use of biomarker testing in dementia diagnosis. She also works on reducing healthcare disparities and improving access to diagnostic tests and treatments. Dr. Schindler has more than 9,500 citations to her research publications. In 2026, she was elected to the American Society for Clinical Investigation.
Explore the NIH-funded blood test using p-tau217 that predicts Alzheimer's symptom onset within 3-4 years, led by WashU researchers. Implications for trials and prevention.
A new blood test using p-tau217 accurately predicts when Alzheimer's symptoms will begin, offering 3-4 year precision from Washington University research.
Explore the new blood test clock from WashU Medicine that predicts Alzheimer's symptoms 3-4 years accurately using p-tau217 levels, implications for trials and patients.